Articles
Safety and efficacy of upadacitinib in patients with active rheumatoid arthritis refractory to biologic disease-modifying anti-rheumatic drugs (SELECT-BEYOND): a double-blind, randomised controlled phase 3 trial
The Lancet
Published: June 13, 2018
Articles
Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trial
The Lancet
Published: June 13, 2018
Articles
Potential effectiveness of long-acting injectable pre-exposure prophylaxis for HIV prevention in men who have sex with men: a modelling study
The Lancet HIV
Published: June 13, 2018
Articles
Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study
The Lancet Infectious Diseases
Published: June 13, 2018
Open Access
Articles
MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial
The Lancet Oncology
Published: June 13, 2018
Viewpoint
Dolutegravir for first-line antiretroviral therapy in low-income and middle-income countries: uncertainties and opportunities for implementation and research
The Lancet HIV
Published: June 5, 2018
Personal View
The dynamic role of dengue cross-reactive immunity: changing the approach to defining vaccine safety and efficacy
The Lancet Infectious Diseases
Published: May 18, 2018
Personal View
The One Health stewardship of colistin as an antibiotic of last resort for human health in South Africa
The Lancet Infectious Diseases
Published: April 16, 2018
Viewpoint
Monitoring country progress and achievements by making global predictions: is the tail wagging the dog?
The Lancet
Published: April 13, 2018
Viewpoint
On reducing the risk of vaccine-associated paralytic poliomyelitis in the global transition from oral to inactivated poliovirus vaccine
The Lancet
Published: March 28, 2018
Articles
Comparative safety of dolutegravir-based or efavirenz-based antiretroviral treatment started during pregnancy in Botswana: an observational study
The Lancet Global Health, Vol. 6, No. 7, e804–e810
Published: June 4, 2018
Open Access
Articles
National, regional, and global prevalence of smoking during pregnancy in the general population: a systematic review and meta-analysis
The Lancet Global Health, Vol. 6, No. 7, e769–e776
Published: May 30, 2018
Open Access
World Report
Ebola outbreak in the DR Congo: lessons learned
The Lancet, Vol. 391, No. 10135, p2096
Published: May 26, 2018
Articles
Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016
The Lancet, Vol. 391, No. 10136, p2236–2271
Published: May 23, 2018
Open Access
Comment
Health-related suffering: from Lancet Commission to DeclarAction
The Lancet, Vol. 391, No. 10135, p2088–2089
Published: May 18, 2018
Comment
New-generation JAK inhibitors: how selective can they be?
The Lancet
Published: June 13, 2018
News
Digestive Disease Week 2018
The Lancet Gastroenterology & Hepatology
Published: June 13, 2018
Comment
The critical importance of retention in HIV prevention
The Lancet HIV
Published: June 13, 2018
Comment
DSM265: a novel drug for single-dose cure of Plasmodium falciparum malaria
The Lancet Infectious Diseases
Published: June 13, 2018
Open Access
Comment
Negative but not futile: MAGE-A3 immunotherapeutic for melanoma
The Lancet Oncology
Published: June 13, 2018